This page includes the latest events details such as registration information, and the first-hand activities record. For further events information, please visit our Chinese Website.
2018 / 08 / 13
Vetco Visited PET SEOUL KAHA 2018 in Korea
Vetco visited PET SEOUL KAHA 2018 in Korea with the representatives of Taiwan Veterinary Association this August. This trip was not merely to introduce the new anti-cancer drug- Antican® to global, but also to learn more about the Korean veterinary market.
2018 / 01 / 26
Never Give UP! The New Hope for Pets – Antican® Market Launch Press Conference in Taiwan
Vetco held the press conference in Jan. 2018, to announce the launching of anti-cancer drug, Antican® in Taiwan. Celebrity Janet Hsieh presented at the press conference calling upon pet owners to be brave for their pets in fighting cancer together, with the newly discovered pet cancer treatment.
2017 / 07 / 13
2017 BIO International Convention- Big Pharmas Expressed High Interest in Antican®
The first product of Vetco Pharmaceuticals Inc. Antican®, an anti-cancer drug for companion animal use, will be launched in Q3, 2017 in Taiwan. Antican®, with its outstanding safety profile and efficacy, and with no chemotherapy side effects, has been highly expected to be introduced to the world. Meanwhile, Vetco seeks partnerships from overseas to develop the global market together, to deliver this extraordinary product to thousands of pet families who look for a hope for their pets.
2017 / 07 / 06
Vetco to Participate in Pet Show in Taiwan from 7/7 - 7/10, 2017
As the very first Taiwan based veterinary pharmaceutical company, Vetco is participating in the 2017 Taiwan Pet Show in Nangang Exhibition Hall from 7/7 – 7/10, as a warm-up for the product launch of Antican® in Taiwan.
2017 / 06 / 11
Vetco to Participate in 2017 BIO International Convention in San Diego
Vetco Pharmaceuticals Inc. is participating in 2017 BIO International Convention in San Diego. Visit us at 2017 Bio International Convention under Taiwan Pavilion! We are providing the first-hand information of the innovative anticancer novel drug Antican® which is worldwide patented.
